A polymorphic Form 1 (-) - 4 - 4 - 4 - (2R CIS - 5 - (2 - difluorfenil tetrahydro - 5 - (1H) - 1,2,4-triazole - 1 - methyl - 3 - il) furan methoxy phenyl - 1-piperazinyl phenyl - 2,Dihydro - 4 - 2 - (S) - 1 - (S) - ethyl - 2 - hydroxypropyl - 1,2,4-triazole - 3H - 3-one, Pharmaceutical composition containing it and its use in preparing a Medic

摘要

(1-trimethyl-methyl-polychlorinated dibenzo compounds, 1-trimethyl (1) benzo-trimethyl-methyl-or crystals in the next diffusion window a. X-ray dust, expressed by entertainment D and relative intensity (IR): spacing D (+; - 0.04) IR; average 6.10; average 4.63; width 3.69;3.05 contains this polymorphic substance and a wide range of pharmaceutical ingredients in cosmetics for the treatment of fungal infections in mammals. 4 - [4 - [4 - [(2r-cis) - 5 - (2,4-difluorophenyl) tetrahydro-5 - (1h-1,2,4-sulfur trifluoride)-1-methyl (furan-3-il) methoxy] - 1-pipeerazinil] phenyl-2,4-dihydro-2 - [(s) - 1-ethyl-2 (s) - hydroxypropyl] - 3h-1,2,4-triazol-3-ona is an antifungal drug, which has the following advantages compared with the non patented form of the former technology: low impurity content, stable product qualityIn other words, the physical properties, including color and speed, are more stable, easier to operate and have a longer stability period.